12/09/2025
Breakthrough Cancer Discovery from Duke-NUS
Researchers at Duke-NUS Medical School—a partnership between Duke University in the U.S. and the National University of Singapore—have found a hidden weakness in blood cancers like acute myeloid leukemia (AML).
This weak spot is in how cancer cells make energy and building blocks for growth. In early lab tests, blocking this process killed cancer cells while sparing healthy ones. While this is still early research, it shows promise for developing new treatments for aggressive cancers in the future.
Read the full story here: https://www.duke-nus.edu.sg/newshub/media-releases/multigene-pathways-aml
Scientists from Duke-NUS Medical School and their international collaborators have developed a new computational tool that maps how gene pathways interact in complex biological systems.